Not looking for an immediate turn around because Macro-Market conditions and retail risk tolerance is severely negative right now. However, this sector has huge potential to be a bullish meme in years ahead. Think of getting into Pot Stocks 2.0 before the moon pumps
In 2018–19, the United States Food and Drug Administration (FDA) granted breakthrough therapy...
After confirming bearish double top pattern, it retraced close to the .618 fib level around .23c. Now, we have a triple top and up 20% on no news. They did get listed on OTC US exchange 5 days ago. I would wait for pull back and go long the psychadelic sector (1-3 years).